Molecular Cardiology
251 – 260 of 308
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The Rationale for and Clinical Pharmacology of Prasugrel 5 mg
(
- Contribution to journal › Article
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma : Workflow for Large-Scale Analysis of Biobank Samples
(
- Contribution to journal › Article
-
Mark
COOL AMI EU pilot trial : A multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction
(
- Contribution to journal › Article
-
Mark
Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients with Myocardial Infarction with Non-Obstructive Coronary Artery (MINOCA) Disease
(
- Contribution to journal › Article
-
Mark
Sweden : Coronary and structural heart interventions from 2010 to 2015
(
- Contribution to journal › Scientific review
-
Mark
Oxygen therapy in suspected acute myocardial infarction
(
- Contribution to journal › Article
-
Mark
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
A simplified left ventricular end-diastolic mean wall thickness-to-volume ratio estimated from left ventricular mass and end-diastolic volume distinguishes physiological from pathological hypertrophy
2017) Society for Cardiovascular Magnetic Resonance: 20th Annual Scientific Sessions(
- Contribution to conference › Poster
-
Mark
Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention
(
- Contribution to journal › Article